Lund University, Box 117, 221 00, Lund, Sweden.
, Östra Vallgatan 41, 223 61, Lund, Sweden.
Department of Clinical Chemistry and Pharmacology, Laboratory Lund University, Lund, 22185, Sweden.
University Hospital of North Norway (UNN), 9038, Breivika, Troms, Norway.
University Hospital of North Norway (UNN), 9038, Breivika, Troms, Norway.
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.
Department of Clinical Science, Intervention and Technology, Division of Pediatrics, Karolinska Institutet, Karolinska University. Hospital Huddinge, 14186, Stockholm, Sweden.
Department of Medicine Huddinge, Karolinska Institutet, C2:91 Karolinska University Hospital, Huddinge, SE-141 52, Sweden.
Barnnjursektionen K 88, Astrid Lindgrens Barnsjukhus, Karolinska University Hospital, Stockholm, 141 86, Sweden.
Department of Clinical Chemistry, C1:74 Huddinge, Karolinska University Hospital, Stockholm, SE-141 86, Sweden.
Clinical Chemistry and Pharmacology, Entrance 61, 2Nd Floor, Akademiska Hospital, 751 85, Uppsala, Sweden.
Service de Physiologie-Explorations, Fonctionnelles Renales Hopital Europeen Georges Pompidou, 20 Rue Leblanc, Paris, 75015, France.
Exploration Fonctionnelle Renale Pavillon P, Hopital Edouard Herriot, 5 Place d'Arsonval, 69437, Lyon, Cedex 03, France.
CHU de Bordeaux, Nephrologie-Transplantation-Dialyse, Hopital Pellegrin, Universite de Bordeaux, Place Amelie Raba Leon, Bordeaux, 33076, France.
Renal Transplantation Department, Assistance Publique-Hopitaux de Paris (AP-HP), Hopital Bichat, 46 Rue Henri Huchard, Paris, 75018, France.
Department of Nephrology, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.
Service de Nephrologie Et Immunologie Clinique, CHU de Nantes, 30 Boulevard Jean Monnet, 44093, Nantes, Cedex 1, France.
Department of Nephrology and Organ Transplantation, CHU Rangueil, 1 Avenue J.Poulhes, TSA 50032, 31059, Toulouse, Cedex 9, France.
Transplantation Renale, Hopital Necker, 145 Rue de Sevres, Paris, 75015, France.
Service de Nephrologie, Hemodialyse, Aphereses Et Transplantation Renale, Hopital Michallon, Centre Hospitalier Universitaire Grenoble-Alpes, Boulevard de La Chantourne, La Tronche, 38700, France.
Institute of Public Health, Charité. Universitätsmedizin Berlin, Luisenstrasse 57, Berlin, 10117, Germany.
Institute of Public Health, Charité. Universitätsmedizin Berlin, Luisenstrasse 57, Berlin, 10117, Germany.
Amsterdam UMC, Vrije Universiteit, De Boelelaan 1112, Amsterdam, 1081 HV, the Netherlands.
Service de Nephrologie, Dialyse Et Transplantation Renale, Hopital Nord, CHU de Saint-Etienne, 25 Boulevard Pasteur, 42055, Saint-Etienne, Cedex 2, France.
Department of Public Health and Primary Care, KU Leuven, Campus Kulak, Kortrijk, Belgium.
Department of Nephrology-Dialysis-Transplantation, University of Liège, CHU Sart Tilman, Liège, Belgium; Department of Nephrology-Dialysis-Apheresis, Hôpital Universitaire Carémeau, Nîmes, France.
BACKGROUND: Creatinine-based estimated glomerular filtration rate (eGFR) equations are widely used in clinical practice but exhibit inherent limitations. On the other side, measuring GFR is time consuming and not available in routine clinical practice. We developed and validated machine learning models to assess the trustworthiness (i.e. the ability of equations to estimate measured GFR (mGFR) within 10%, 20% or 30%) of the European Kidney Function Consortium (EKFC) equation at the individual level.
METHODS: This observational study used data from European and US cohorts, comprising 22,343 participants of all ages with available mGFR results. Four machine learning and two traditional logistic regression models were trained on a cohort of 9,202 participants to predict the likelihood of the EKFC creatinine-derived eGFR falling within 30% (p30), 20% (p20) or 10% (p10) of the mGFR value. The algorithms were internally and then externally validated on cohorts of respectively 3,034 and 10,107 participants. The predictors included in the models were creatinine, age, sex, height, weight, and EKFC.
RESULTS: The random forest model was the most robust model. In the external validation cohort, the model achieved an area under the curve of 0.675 (95%CI 0.660;0.690) and an accuracy of 0.716 (95%CI 0.707;0.725) for the P30 criterion. Sensitivity was 0.756 (95%CI 0.747;0.765) and specificity was 0.485 (95%CI 0.460; 0.511) at the 80% probability level that EKFC falls within 30% of mGFR. At the population level, the PPV of this machine learning model was 89.5%, higher than the EKFC P30 of 85.2%. A free web-application was developed to allow the physician to assess the trustworthiness of EKFC at the individual level.
CONCLUSIONS: A strategy using machine learning model marginally improves the trustworthiness of GFR estimation at the population level. An additional value of this approach lies in its ability to provide assessments at the individual level.
BioMed Central (BMC), 2025. Vol. 26, no 1, article id 47
Chronic kidney disease, Creatinine, Glomerular filtration rate, Machine learning, Random forest